DIAGALS: Relation Between Tar DNA Binding Protein(TDP)-43 et Nrf-2 in ALS: a Track to Improve Diagnosis and Prognosis of the Disease

计划入组 60 人 · 首次发布于 2024 年 1 月 30 日

Tamoxifen Treatment in Patients With Motor Neuron Disease

计划入组 20 人 · 首次发布于 2014 年 6 月 18 日

Heparin-Binding Protein and Heparins

计划入组 60 人 · 首次发布于 2019 年 10 月 31 日

broad spectrum anti-TAR DNA-binding protein oligomer

broad spectrum anti-TAR DNA-binding protein oligomer (Treventis)

VEZF1/DNA binding inhibitors (Vasculomedics)

Protein Sciences Corporation

United States

DNA International Hospital

Vietnam

Ginkgo Bioworks

United States

FDA Clears First-in-Class Vectorized Antibody Trial for ALS Targeting TDP-43 Pathology

Edaravone Shows Promise in Targeting TDP-43 Mislocalization in ALS, New Preclinical Research Reveals

UCLA Develops SEE-CITE Technology to Enhance Precision in Drug Discovery and Protein Binding Analysis